ORION NUTRACEUTICALS INC

Share · CA68629J2056 · A2P45H (XCNQ)

Overview

No Price

n/a

Share Float & Liquidity

Free Float 98,64 %

Shares Float 28,91 M

Shares Outstanding 29,31 M

Company Profile for ORION NUTRACEUTICALS INC Share

Orion Nutraceuticals Inc. focuses on the drug for treating asthma and chronic obstructive pulmonary diseases in Canada. The company was formerly known as Cline Capital Corp. Orion Nutraceuticals Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Get up to date insights from finAgent about ORION NUTRACEUTICALS INC

Company Data

Name ORION NUTRACEUTICALS INC

Company Orion Nutraceuticals Inc.

Website https://www.orionnutra.ca

Primary Exchange

CSE LISTED

WKN A2P45H

ISIN CA68629J2056

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Joel S. Dumaresq

Market Capitalization 12 Mio

Country Canada

Currency EUR

Employees -

Address 789 West Pender Street, V6C 1H2 Vancouver

IPO Date 2018-10-17

Ticker Symbols

Name	Symbol
CSE LISTED	ORI.CN
Frankfurt	86OA.F

More Shares

Investors who hold ORION NUTRACEUTICALS INC also have the following shares in their portfolio:

BPCE S.A. 17/27 MTN REGS Bond

NATIONAL EXHIBITION CENTRE (DEVELOPMENTS) PLC 7.5625% GTD UNS LN STK 2027 #(VAR) Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog